Hong Kong-based AI-driven company sells potential breast can

Stemline Therapeutics, a wholly-owned unit of Menarini Group, will make a US$12 million upfront payment to Insilico under the agreement, which will be followed by sales royalties worth up to ‘double digits’.

Related Keywords

Canada , China , Hong Kong , Saudi Arabia , New York , United States , Qiming , Sichuan , Elcin Barker Ergun , Alex Zhavoronkov , Abu Dhabi , Warburg Pincus , Precedence Research , Quantum Computing Research , World Health Organization , B Capital Group , Development Center , Vantage Market Research , Vantage Market , World Health , Greater China , Hong Kong Based Qiming , Insilico Medicine , Menarini Group , Temline , Prosperity7 , Qiming Ventures ,